“Even Damien Hirst may not be immune to the economic climate – many of the workers who produce his works found themselves out of a job this week, the Guardian has learned. On Thursday, up to 17 of the 22 people who make the pills for Hirst’s drug cabinet series were told their contracts were not being renewed.”